These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1965007)

  • 21. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal treatment in patients with cancer.
    Viscoli C; Castagnola E; Machetti M
    J Intern Med Suppl; 1997; 740():89-94. PubMed ID: 9350188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
    Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
    Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
    Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ
    Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD; Ghent C; Grant D; Horbay GL; McDougal J; David Colby W
    Transplantation; 2003 Sep; 76(6):977-83. PubMed ID: 14508365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
    Rimek D; Redetzke K; Kappe R
    Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy.
    Wang CY; Wu BY; Guo KY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):389-90. PubMed ID: 12697487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ; Michalopoulos A; Falagas ME
    Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Itraconazole in systemic fungal infections].
    Denning DW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():3-4. PubMed ID: 1663203
    [No Abstract]   [Full Text] [Related]  

  • 33. Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels.
    Boogaerts MA; Verhoef GE; Zachee P; Demuynck H; Verbist L; De Beule K
    Mycoses; 1989; 32 Suppl 1():103-8. PubMed ID: 2561181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.
    Tricot G; Joosten E; Boogaerts MA; Vande Pitte J; Cauwenbergh G
    Rev Infect Dis; 1987; 9 Suppl 1():S94-9. PubMed ID: 3027853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylaxis of fungal infections with itraconazole during remission-induction therapy.
    Prentice AG; Bradford GR
    Mycoses; 1989; 32 Suppl 1():96-102. PubMed ID: 2561190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal treatment strategy in leukemia patients.
    Büchner T; Roos N
    Ann Hematol; 1992 Oct; 65(4):153-61. PubMed ID: 1329995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of neonatal Candida albicans septicemia with itraconazole.
    van den Anker JN
    Pediatr Infect Dis J; 1992 Aug; 11(8):684-5. PubMed ID: 1326096
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT.
    Trigg ME; Menezes AH; Giller R; Lanza L; Smith RJ; Sato Y; Peters C; Altman A
    Bone Marrow Transplant; 1993 Jun; 11(6):493-6. PubMed ID: 8392887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of deep mycoses with itraconazole.
    Kumar B; Kaur I; Chakrabarti A; Sharma VK
    Mycopathologia; 1991 Sep; 115(3):169-74. PubMed ID: 1660959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients.
    Mühldorfer SM; König HJ
    Mycoses; 1990 Jun; 33(6):291-5. PubMed ID: 2175392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.